id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0202-0007,FDA,FDA-2009-E-0202,Determination of Regulatory Review Period for Purposes of Patent Extension: LUSEDRA,Notice,N-Notice,2010-04-05T04:00:00Z,2010,4,2010-04-05T04:00:00Z,2010-06-05T03:59:59Z,2010-04-22T16:02:46Z,2010-07516,0,0,0900006480ad0501
FDA-2009-E-0202-0006,FDA,FDA-2009-E-0202,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-24T04:00:00Z,2010,3,2010-03-24T04:00:00Z,,2013-07-27T23:13:11Z,,0,0,0900006480ac7884